Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Herceptin image

Injectable Herceptin proves its worth

October 20, 2011
Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …

News
Roche

Roche buys US firm Anadys for $230 million

October 17, 2011
Research and Development, Sales and Marketing Roche, hepatitis C

Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …

News
Roche

Roche revenue drops as key products underperform

October 13, 2011
Sales and Marketing Roche

Roche has posted worse-than-expected figures for the first nine months of this year after key products failed to shine and …

News
Roche Nutley

Manufacturing makes a comeback at Roche’s Nutley site

October 4, 2011
Manufacturing and Production Roche, pharma manufacturing news

Roche has opened a new manufacturing facility at its campus in Nutley, New Jersey, that will supply dosage forms for …

News

Roche’s Herceptin successor impresses at EMCC

September 27, 2011
Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …

News

Roche cleared over rep conduct complaint

September 23, 2011
Sales and Marketing ABPI Code of Practice, Roche

Roche has been cleared by Code regulator the PMCPA of any wrongdoing after an NHS employee complained about the promotion …

News

Roche to show new cancer data at European congress

September 20, 2011
Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …

News
Roche

Roche and Evotec to develop Alzheimer’s drug

September 6, 2011
Alzheimer's disease, Evotec, Roche

Roche and Evotec are to collaborate on the development and commercialisation of Evotec’s MAO-B inhibitor in patients with Alzheimer’s disease. …

News
Roche's Tarceva (erlotinib)

Tarceva approval for first-line use in EGFR lung cancer

September 1, 2011
Sales and Marketing NSCLC, Roche, Tarceva

Tarceva has been granted final European approval for patients with a genetically distinct type of non-small cell lung cancer (NSCLC). …

News
FDA

Roche skin cancer drug approval ‘imminent’

August 11, 2011
Sales and Marketing Roche, melanoma, vemurafenib

 Skin cancer treatment Zelboraf looks set to gain FDA approval months ahead of schedule. Roche and Daiichi Sankyo’s drug is …

News

NICE wants more RoActemra data for juvenile idiopathic arthritis

August 9, 2011
Medical Communications NICE, RoActemra, Roche

NICE has requested more evidence from Roche for RoActemra in childhood arthritis. RoActemra (tocilizumab) is being assessed for the treatment …

News

Investment firm adds Roche facility to growing portfolio

August 9, 2011
Manufacturing and Production Colarado, International Chemical Investors, Roche, pharma manufacturing news

International Chemical Investors Group has snapped up another manufacturing facility, this time agreeing to buy a plant owned by Roche …

News

First personalised asthma drug shows promise

August 4, 2011
Roche, asthma, personalised medicine

Roche’s personalised asthma drug lebrikizumab has met its primary end point in a phase II trial. Lebrikizumab increased the level …

News
Roche's Tarceva (erlotinib)

Roche cancer drug Tarceva set for first-line licence

July 25, 2011
Sales and Marketing Cancer, Roche, Tarceva

Roche’s cancer drug Tarceva is on course to win a first-line indication in Europe for the first time after regulatory …

News

Merck and Roche extend Victrelis co-promotion deal to Europe

July 22, 2011
Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C

Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026